Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$517M |
| 2 |
NXP Semiconductors
NXPI
|
+$351M |
| 3 |
Oracle
ORCL
|
+$279M |
| 4 |
Palo Alto Networks
PANW
|
+$268M |
| 5 |
Boston Scientific
BSX
|
+$204M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CERN
Cerner Corp
CERN
|
+$517M |
| 2 |
ExxonMobil
XOM
|
+$385M |
| 3 |
Cenovus Energy
CVE
|
+$292M |
| 4 |
PLAN
Anaplan, Inc.
PLAN
|
+$236M |
| 5 |
Phillips 66
PSX
|
+$222M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 55.01% |
| 2 | Technology | 7.76% |
| 3 | Financials | 7.66% |
| 4 | Healthcare | 7.12% |
| 5 | Industrials | 5.11% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SOHU
3351
Sohu.com
SOHU
$368M
| $2.71M | ﹤0.01% |
163,295
-29,338
| -15% | -$458K |
|
3352
Fulgent Genetics
FLGT
$540M
| $2.7M | ﹤0.01% |
49,575
-231,361
| -82% | -$12.7M |
|
3353
EyePoint Inc
EYPT
$386M
| $2.7M | ﹤0.01% |
343,223
+187,958
| +121% | +$1.89M |
|
3354
CALL
Best Buy
BBY
$17.4B
| $2.7M | ﹤0.01% |
41,400
-21,900
| -35% | -$1.83M |
|
3355
PUT
KKR & Co
KKR
$97.6B
| $2.69M | ﹤0.01% |
58,200
+48,900
| +526% | +$2.57M |
|
3356
PUT
Fortive
FTV
$18B
| $2.69M | ﹤0.01% |
+65,687
| New | +$2.91M |
|
3357
Alaunos Therapeutics
TCRT
$4.06M
| $2.69M | ﹤0.01% |
14,465
+10,852
| +300% | +$1.04M |
|
3358
PUT
Roblox
RBLX
$27.5B
| $2.69M | ﹤0.01% |
81,800
+11,800
| +17% | +$396K |
|
|
BWIN
3359
Baldwin Insurance Group
BWIN
$2.97B
| $2.69M | ﹤0.01% |
111,255
-277,666
| -71% | -$6.75M |
|
3360
Coca-Cola Consolidated
COKE
$13.2B
| $2.68M | ﹤0.01% |
47,460
+22,540
| +90% | +$1.18M |
|
|
AFCG
3361
AFC Gamma
AFCG
$81.2M
| $2.67M | ﹤0.01% |
254,353
-20,159
| -7% | -$236K |
|
3362
SiriusXM
SIRI
$9.62B
| $2.67M | ﹤0.01% |
43,525
-403,728
| -90% | -$25.1M |
|
|
KZR
3363
CALL
DELISTED
Kezar Life Sciences
KZR
| $2.67M | ﹤0.01% |
32,240
+27,240
| +545% | +$2.4M |
|
|
WPRT
3364
Westport Fuel Systems
WPRT
$35M
| $2.66M | ﹤0.01% |
263,770
+94,267
| +56% | +$1.17M |
|
3365
Corvus Pharmaceuticals
CRVS
$1.19B
| $2.66M | ﹤0.01% |
2,687,943
-35,596
| -1% | -$43.7K |
|
3366
CALL
Crown Castle
CCI
$32.4B
| $2.66M | ﹤0.01% |
15,800
+1,100
| +7% | +$200K |
|
3367
Oramed Pharmaceuticals
ORMP
$209M
| $2.66M | ﹤0.01% |
580,383
+216,823
| +60% | +$1.16M |
|
|
RPT
3368
Rithm Property Trust
RPT
$100M
| $2.65M | ﹤0.01% |
46,141
+38,283
| +487% | +$2.29M |
|
3369
SL Green Realty
SLG
$4.08B
| $2.65M | ﹤0.01% |
57,415
-190,927
| -77% | -$12.1M |
|
|
IQMD
3370
DELISTED
Intelligent Medicine Acquisition Corp. Class A Common Stock
IQMD
| $2.65M | ﹤0.01% |
+264,160
| New | +$2.64M |
|
|
CFIV
3371
DELISTED
CF Acquisition Corp. IV Class A common stock
CFIV
| $2.65M | ﹤0.01% |
268,758
+12,631
| +5% | +$124K |
|
|
FRBN
3372
DELISTED
Forbion European Acquisition Corp. Class A Ordinary Shares
FRBN
| $2.65M | ﹤0.01% |
264,482
+215,354
| +438% | +$2.15M |
|
|
GRTS
3373
DELISTED
Gritstone bio, Inc. Common Stock
GRTS
| $2.64M | ﹤0.01% |
1,091,467
+488,923
| +81% | +$1.28M |
|
3374
CytomX Therapeutics
CTMX
$699M
| $2.64M | ﹤0.01% |
1,441,732
-803,458
| -36% | -$1.54M |
|
|
WW
3375
DELISTED
WW International
WW
| $2.64M | ﹤0.01% |
412,805
-203,275
| -33% | -$1.71M |
|
Similar funds
Israel Englander's Q2 2022 Portfolio in Review
As of Q2 2022, Israel Englander held 7,971 positions worth $161B, down 15% from $189B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Israel Englander deployed $8.78B of net new capital in Q2 2022, opening 1,144 new positions and adding to 2,588 existing holdings. Its largest new stake was M&T Bank: 828,809 shares worth $132M.
By sector, the portfolio is most concentrated in Miscellaneous at 55% of assets, down from 60% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was ExxonMobil, an estimated $385M trimmed.
- Israel Englander's largest Q2 2022 buy was M&T Bank: 828,809 shares worth $132M.
- Israel Englander added most to Invesco QQQ Trust in Q2 2022, an estimated $517M increase.
- Israel Englander's biggest Q2 2022 reduction was ExxonMobil, cutting an estimated $385M.
- Israel Englander fully exited Cerner Corp in Q2 2022, selling an estimated $517M.
- Israel Englander's ten largest holdings make up 23% of its $161B portfolio in Q2 2022.
- Israel Englander opened 1,144 new positions and closed 1,065 in Q2 2022.
- Israel Englander's portfolio value fell 15% quarter-over-quarter to $161B.
Based on Millennium Management's 13F filing for Q2 2022, filed 15 Aug 2022.